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ABSTRACT
Small non-coding RNAs (sRNAs) are an emerging
class of post-transcriptional regulators of bacterial
gene expression. To study sRNAs and their potential
protein interaction partners, it is desirable to
purify sRNAs from cells in their native form. Here,
we used RNA-based affinity chromatography to
purify sRNAs following their expression as
aptamer-tagged variants in vivo. To this end, we
developed a family of plasmids to express sRNAs
with any of three widely used aptamer sequences
(MS2, boxB, eIF4A), and systematically tested
how the aptamer tagging impacted on intra-
cellular accumulation and target regulation of the
Salmonella GcvB, InvR or RybB sRNAs. In addition,
we successfully tagged the chromosomal rybB
gene with MS2 to observe that RybB-MS2 is fully
functional as an envelope stress-induced repressor
of ompN mRNA following induction of sigmaE. We
further demonstrate that the common sRNA-binding
protein, Hfq, co-purifies with MS2-tagged sRNAs
of Salmonella. The presented affinity purification
strategy may facilitate the isolation of in vivo
assembled sRNA–protein complexes in a wide
range of bacteria.
INTRODUCTION
Throughout their life cycle, small non-coding RNAs
(sRNAs) that function as regulators of gene expression
may interact with a variety of proteins. These include
proteins that govern the maturation, turnover or
intracellular transport of sRNAs; target proteins whose
in vivo functions are modulated by an sRNA; and the
auxiliary factors that help sRNAs recognize non-protein
targets such as RNA, DNA or small metabolites. Over the
years, various strategies have been used to isolate proteins
along with RNA by means of RNA-based aﬃnity
chromatographic methods. The most direct approach is
the immobilization of the RNA of interest on a column
to which then cellular protein fractions are applied. For
immobilization, in vitro-synthesized unmodiﬁed bait RNA
is covalently coupled to cyanogen bromide (CNBr)-
activated sepharose (1). Alternatively, modiﬁcation of an
in vitro-synthesized RNA can be used to facilitate its
covalent or non-covalent attachment to the solid phase
(2–5). Collectively, these methods rely upon RNA–
protein interaction to take place after cellular lysate
preparation, and therefore do not allow the isolation of
in vivo assembled RNA–protein complexes.
To identify RNA-associated proteins, it remains
desirable to purify a given RNA from its native source.
Therefore, other strategies were developed in which a
highly speciﬁc and non-covalent interaction with the
RNA moiety is used for selection of, for example,
eukaryotic ribonucleoprotein particles (RNPs) under
non-denaturating conditions. Initially, biotinylated
antisense oligonucleotides complementary to accessible,
single-stranded regions of the RNP-contained RNA
were used as aﬃnity baits (6,7). More recently, the
addition of diverse natural or in vitro selected RNA
aptamer sequences to the RNA of interest has provided
a convenient tool for RNP separation and puriﬁcation;
these aptamers bind their ligands with an aﬃnity similar
to that observed for natural antibodies. Aptamer tags
speciﬁc for small molecules, e.g. streptavidin (8), strep-
tomycin (9,10), or tobramycin (11), or for proteins and
peptides, e.g. MS2 coat protein (12–14) and  N22 peptide
(15,16), were successfully used for the isolation of a variety
of RNPs. Recently, two RNA aptamers, one speciﬁc
for the Pseudomonas phage 7 coat protein and the other
for tobramycin, were used in combination for RNP
puriﬁcation (17).
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with diverse physiological functions (18–23). These sRNAs
are typically 50–250 nucleotides in length, diﬀer in
structure from each other, and are generally untranslated.
Depending on their mode of action, some bacterial sRNAs
directly target proteins, e.g. 6S RNA which binds to and
modiﬁes the sigma factor aﬃnity of RNA polymerase (24),
or the family of CsrB-like RNAs which antagonizes CsrA/
RsmA-like regulatory proteins (25,26).
The major class of regulatory sRNAs in bacteria targets
trans-encoded mRNAs by antisense pairing (27). Target
pairing is generally short and imperfect, and most often
requires the bacterial Sm-like protein, Hfq, for successful
target interaction (28,29). Recent co-immunoprecipitation
experiments showed that up to half of all known
Escherichia coli or Salmonella sRNAs may bind Hfq
in vivo (30–32). However, we generally know little about
the nature and number of proteins bacterial sRNAs
associate with throughout their life time as regulators (33).
In this work, we have studied whether aptamer-tagging
can be used to recover in vivo expressed regulatory sRNAs
of Salmonella along with the commonly associated
Hfq protein. We selected for study three structurally
unrelated Salmonella sRNAs, i.e. GcvB, InvR and RybB
(Figure 1A). Collectively, these sRNAs repress trans-
encoded target mRNAs by Hfq-dependent base-pairing
mechanisms. GcvB is a widely conserved 200nt RNA
which was originally identiﬁed in E. coli (34) and
recently shown to directly target many Salmonella ABC
transporter mRNAs (35); one of its targets is the oppA
mRNA encoding a function in the major oligopeptide
transport system. InvR (80nt) RNA is expressed from
the Salmonella-speciﬁc invasion gene island, and targets
ompD mRNA encoding the major outer membrane
protein of Salmonella under conditions of eukaryotic
host cell invasion (36). The 80nt RybB RNA also down-
regulates outer membrane protein (OMP) synthesis yet
in a rather global fashion; when overproduction of
OMPs causes envelope instability, RybB expression is
activated by the specialized sigma factor, s
E, and the
sRNA then promotes the rapid decay of all major and
many minor omp mRNAs of Salmonella to restore
envelope homeostasis (37).
We have tested how the addition of any of three well-
investigated aptamer sequences (MS2, boxB, eIF4A;
Figure 1B) impacts on the expression levels and regulatory
properties of sRNAs, and have successfully used MS2
aptamer-tagged GcvB, InvR or RybB RNAs for Hfq
co-puriﬁcation from Salmonella extracts. We provide an
optimized protocol for aﬃnity puriﬁcation of MS2
aptamer-tagged sRNAs that may facilitate the isolation
of in vivo assembled sRNA–protein complexes in a wide
range of bacteria. Our protocol further proves useful
for the subsequent proteome analysis of the puriﬁed
complexes by mass spectrometry.
MATERIALS AND METHODS
Plasmid construction
DNA oligonucleotides and plasmids used in this study
are listed in Supplementary Tables S1 and S2. In the
following, a detailed description of the construction
of GcvB aptamer expression plasmids and the control
plasmids is given. The details of the RybB/InvR
expression plasmids are found in the Supplementary
Text and Table S2.
For GcvB plasmids pNS-7 and pNS-8, plasmid pTP005
was ampliﬁed with primer pairs JVO-2660/-2661
(introduce MS2 tag), and JVO-2658/-2659 (introduce
eIF4A tag) and the PCR product was re-ligated.
To construct the general vectors, two complemen-
tary oligodesoxynucleotides, JVO-2750 and JVO-2751
containing the 1xboxB aptamer ﬂanked by NheI and
XbaI cleavage sites and the vrrA sequence ﬂanked by
the AvrII restriction site, were annealed and digested
with AvrII. The DNA fragment was inserted by blunt-
end/AvrII-XbaI cloning into plasmid vector pJV752. The
resulting plasmid, pNS-18, which now harbored
the 1xboxB aptamer cassette, subsequently served as the
parental plasmid for construction of additional general
aptamer plasmids that carry 4xboxB (pNS-20), eIF4A
(pNS-19) or MS2* (pNS-21) cassettes. To this end, the
1xboxB cassette was excised from pNS-18 by NheI/XbaI
digest, and replaced with NheI/XbaI treated DNA
fragment with the new aptamer sequence. Inserts were
obtained by PCR with primer JVO-2754/2755 for
eIF4A, or JVO-2756/-2757 for MS2*, and using
plasmids pNS-3 or pMS2* respectively, as PCR templates.
The 4xboxB aptamer fragment was obtained by annealing
complementary oligodesoxynucleotides JVO-2752 and
JVO-2753.
To construct plasmids in which GcvB sRNA is
30-end-tagged with an aptamer, the gcvB gene of plasmid
pTP005 was ampliﬁed with primer pair pZE-A/JVO-2956,
which yielded the sRNA gene but without the native
gcvB terminator, and with a NheI restriction site at
the 30 of the gene fragment. These fragments were
digested with XhoI and NheI, and inserted into the afore-
mentioned general aptamer vectors (pNS-18, pNS-19,
pNS-20 or pNS-21) (note that XhoI cloning remove the
plasmid-borne PLlacO-1 promoter, thus the sRNA
fragment must contain the native sRNA promoter).
This gave yield to plasmids pNS-22, pNS-27, pNS-31
and pNS-32.
Control vector, pNS-17, was generated by NheI/XbaI
digest of plasmid pNS-18, followed by re-ligation of the
vector backbone. This control plasmid expresses a  80nt
nonsense RNA that corresponds to the rrnB terminator
of the plasmid and vector sequences upstream of the
terminator.
To construct the MS2 control plasmid pRR-05, which
expresses a short MS2 tag RNA, plasmid pNS-10 was
ampliﬁed with primer pair JVO-1745/-3446, and religated.
All plasmids used throughout this study were
introduced into Salmonella by electroporation as des-
cribed (38).
Bacterial strains and growth conditions
Salmonella strain JVS-2999, which is a non-infectious
aroA mutant of Salmonella enterica serovar Typhimurium,
is referred to as the Salmonella wild-type strain
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SL7207 strain (2337–65 (WRAY) hisG46aroA407
(Tc
saroA544::Tn10) as published (39), and was kindly
provided by the Department of Immunology at the MPI
for Infection Biology, Berlin, Germany. For experiments
in Figure 7B, the virulent Salmonella strain SL1344
(JVS-0007) was used.
The derivatives of JVS-2999 carrying sRNA deletions
(JVS-3008, invR::Km
R; JVS-3142, rybB::Km
R;
JVS-3143, gcvB::Km
R) and/or an epitope-tagged hfq
gene (JVS-3618, hfq::3xFLAG invR::Km
R; JVS-3789,
hfq::3xFLAG rybB::Km
R; JVS-3790, hfq::3xFLAG
gcvB::Km
R) were constructed by phage P22 trans-
duction of previously published strains as outlined in
Supplementary Table S3.
To express endogenous RybB-MS2, we adapted the
 Red recombinase method for one-step inactivation of
chromosomal genes (40). The DNA fragment to be
integrated (contains the aptamer-tagged sRNA of pNS-
14 fused to the kanamycin resistance cassette of pKD4)
was generated via overlapping PCR: the two DNA
fragments obtained by PCR with primer pair JVO-906/
3516 on pNS-14 and primer pair JVO-0203/3517 on
pKD4 were mixed in equimolar amounts and used as
template for a PCR with primer pairs JVO-3515/3521.
The chromosomal RybB-MS2 mutation was subsequently
transferred to strains JVS-0007 and JVS-3617, which
results in JVS-4892 (used for functional studies in
Figure 7B) and JVS-4279 (used for aﬃnity puriﬁcation
in Figure 7C).
Bacterial strains were grown in LB (Lennox) broth at
37 C, 220r.p.m., throughout this study. Antibiotics
(where appropriate) were used at the following con-
centrations: 100mg/ml ampicillin, 50mg/ml kanamycin.
Sample preparation
Whole cell protein samples were prepared as follows:
bacteria were cultured to an OD600 of 1(for GcvB
samples) or an OD600 of 2(InvR, RybB) and samples
equivalent to 0.5OD600 (e.g. 0.5ml of an OD600 of one
culture) were removed and centrifuged for 2min at
15800g at 4 C. The pellet was suspended in 100ml1  
protein loading buﬀer (Fermentas; #R0891). Proteins
were denatured for 5min at 96 C, and separated by
sodium dodecyl sulfate (SDS)–polyacrylamide
gelelectrophoresis (PAGE) using 15% polyacrylamide
gels.
For isolation of total RNA, samples equivalent to 2
OD600 were centrifuged as described earlier.
The pellet was dissolved in 1ml TRIzol Reagent
(Invitrogen), and RNA was isolated and precipitated
as described (38). The precipitated RNA was directly dis-
solved in 20ml loading buﬀer II (Ambion, #AM8548G)
and denatured for 3min at 95 C. Ten microliters of each
RNA sample were separated on 6% polyacrylamide/8.3M
urea gels.
To analyze chromosmal MS2-tagged RybB (Figure 7B),
bacteria were cultered to an OD600 of 1, at which sRNA
expression was induced with L-arabinose for 10min.
Culture aliquots equivalent to 4 OD600 were removed,
mixed with 0.2 volumes of stop solution (5% water-
saturated phenol, 95% ethanol) and snap-frozen in liquid
nitrogen. After thawing on ice, bacteria were pelleted and
the RNA was isolated as described earlier. The puriﬁed
RNA was quantiﬁed on a Nanodrop Machine
(NanoDrop Technologies). RNA samples ( 6mg) were
denatured for 3min at 95 C in loading buﬀer II and
separated on 6% polyacrylamide/8.3M urea gels.
Puriﬁcation of MS2-MBP fusion protein
For use as an aﬃnity tag, MS2 coat protein fused to
maltose-binding protein (MS2-MBP) was expressed in
E. coli. This fusion places the maltose binding protein
N-terminal to MS2 coat protein which carries a double
mutation that prevents oligomerization (41). The fusion
protein was puriﬁed ﬁrst over an amylose (NEB) column
in 20mM HEPES pH 7.9, 200mM KCl, 1mM EDTA,
and then over a heparin column using a KCl gradient in
the same buﬀer (42). Purity of the protein was evaluated
by SDS–PAGE and Commassie brilliant blue staining.
Aﬃnity puriﬁcation
The Salmonella strains indicated in ﬁgure legends were
grown under standard laboratory conditions to an
OD600 of 1 (GcvB) or 2 (InvR, RybB). Samples for the
whole cell protein and the total RNA (culture samples)
were prepared as described earlier. For aﬃnity puriﬁ-
cation, cells equivalent to 50 OD600 were chilled on ice
for 20min and harvested (20min, 2900g,4  C). Cells
were resuspended in 1ml Buﬀer A (20mM Tris–HCl pH
8.0, 150mM KCl, 1mM MgCl2, 1mM DTT) and then
cells were subsequently centrifuged (5min, 11200g,4  C)
and the pellets were shock-frozen in liquid nitrogen and
stored at  80 C.
Frozen pellets were thawed on ice, resuspended in
2ml Buﬀer A, followed by cell breakage using a French
press (French Pressure Cell Press, SLM instruments).
A pressure of 800psi was applied to the cells for three
times; the lysate was chilled on ice between every step.
The lysate was cleared by centrifugation (30min,
30000g,4  C) and the soluble fraction subjected to
aﬃnity chromatography.
All steps for aﬃnity puriﬁcation were performed at 4 C.
For preparation of the aﬃnity column, 50ml amylose
resin (New England Biolabs, #E8021S) was applied to
Bio-Spin disposable chromatography columns (BioRad,
#732-6008). The prepared column was washed three
times with 2ml Buﬀer A. Next, 100pmol MS2-MBP
coat protein (diluted in 1ml Buﬀer A) was immobilized
on the amylose resin, and the column was washed with
2ml of Buﬀer A (for the experiments in Figure 6, 100ml
amylose resin and 1200pmol MS2-MBP were used).
Subsequently, the cleared bacterial lysate was loaded
onto the column, followed by three washes with 2ml
Buﬀer A. For RNA analysis, aliquots equivalent to 2
OD600 of the lysate, the ﬂow-through and the wash
fractions were treated with 1ml TRIzol reagent as
described earlier. For protein analysis, aliquots equivalent
to 0.5 OD600 were mixed with protein loading buﬀer to a
ﬁnal volume of 100ml.
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column with 900ml of Buﬀer A containing 12mM
maltose. Eluted RNA was extracted with phenol–
chloroform–isoamylalcohol [25:24:1 (v/v), Roth],
followed by ethanol (3vol) precipitation of the aqueous
phase in the presence of 20mg yeast tRNA. Once
re-dissolved in 25ml water, the RNA was stored at
 20 C. For protein isolation, the organic phase was
subjected to acetone precipitation at  20 C over night.
The pellet was washed twice with acetone and air-dried.
The pellet was solved in 50ml1   protein loading buﬀer.
For analysis of inﬂuence of diﬀerent parameters on aﬃnity
puriﬁcation changing conditions were used as indicated in
the legend of Figure 6 and Supplementary Figure S4.
For the isolation of endogenous expressed RybB-MS2
(Figure 7C), some parameters were modiﬁed. JVS-2999
and JVS-4279, both harboring pBAD-RpoE, were
grown to an OD600 of 1nm, at which sRNA expression
was induced with L-arabinose for 5min. Cells equivalent
to 200 OD600 were chilled at  10 C for 5min and
harvested (20min, 2900g,4  C). The lysate was prepared
as described above, cleared by centrifugation (15min,
2900g,4  C) and the soluble fraction was subjected to
aﬃnity chromatography in which 100ml amylose resin
and 300pmol MS2-MBP coat protein were used.
Isolation of tagged sRNAs and co-puriﬁcation of Hfq
was performed in triplicates, and results were consistent.
The results of representative experiments are shown.
Mass spectrometry
For mass spectrometric analysis of InvR associated
proteins, precipitated proteins were dissolved in 1 
protein loading buﬀer and loaded onto a 4–12%
NuPAGE-Gel (Invitrogen). After Coomassie stain gel
lanes of aﬃnity puriﬁed InvR-MS2 and InvR were cut
into 23 slices and proteins therein are digested with
Trypsin according to (43). Extracted peptides were
analyzed by LC-MSMS on an Orbitrap XL instrument
(ThermoFisherScientiﬁc) under standard conditions.
Peptide fragment spectra were searched against a target-
decoy database for Salmonella typhimurium strain LT2
(M. Selbach, personal communication) using MASCOT
as search engine.
Northern blot analysis
After polyacrylamide gel electrophoresis, the RNA was
transferred to Hybond-XL membranes (GE Healthcare)
by electro-blotting (1h, 50V, 4 C) in a tank electro
blotter (Peqlab, #52-WEB-20), and cross-linked to
membrane by exposure to UV light (302nm) for 4min.
The GcvB, InvR, RybB sRNA and the RNA with the
MS2 tag alone were detected using g-[
32P] ATP 50-end-
labeled oligodeoxyribonucleotides JVO-0749 (antisense to
nucleotides 4–20 of GcvB RNA), JVO-0222 (antisense
to nucleotides 19–44 of InvR RNA), JVO-2644 (antisense
to nucleotides 5–24 of RybB RNA), and JVO 3562
(antisense to nucleotides 8–31 of the MS2 aptamer),
respectively. 5S rRNA (loading control) was detected
with oligo JVO-0322; ompN mRNA was detected as
described previously (37).
Prehybridization and hybridization of membranes
with oligonucleotides was carried out each for 1h in
Roti-Hybri-Quick buﬀer (Roth) at 42 C. Following
hybridization, membranes were rinsed in 5  SSC,
followed by three washing steps at 42 C for 15min in
SSC (5 ,1   and 0.5 )/0.1% SDS solutions. Signals
were visualized on a phosphorimager (Phosphorimager,
FLA-3000 Series, Fuji), and band intensities quantiﬁed
with AIDA software (Raytest, Germany).
Western blot analysis and silver staining
For western blot analysis, polyvinylidene diﬂuoride
membrane (PVDF, PerkinElmer) was activated by
incubation in methanol (90s), H2O (5min) and transfer
buﬀer (5min), respectively. After SDS–PAGE, the gel was
blotted for 2h at 2mA/cm
2 and 4 C in a semi-dry electro
blotter (Peqlab, #52–2020) onto the PVDF membrane in
transfer buﬀer. After rinsing in TBST20, the membrane
was incubated over night in 10% dry milk in TBTS20.
OppA or Hfq
3 FLAG proteins, and the major OMPs,
were detected using a polyclonal serum against OppA
(1:3000 in TBST20-BSA), porin antiserum, which detects
major porin such as OmpA/C/D/F (1:20000 in TBST20-
BSA, provided by R. Misra) or a monoclonal anti-FLAG
antibody (Sigma-Aldrich, #F2555, 1:1000 in TBST20-
BSA), for 1h at room temperature under agitation.
Membranes were washed 5 6min in TBST20, incubated
with either anti-mouse–horseradish peroxidase or anti-
rabbit–horseradish peroxidase (GE Healthcare, 1:5000 in
TBST20-BSA) for 1h at room temperature and washed
again 6 10min in TBST20. Blots were analysed using
Western Lightning Reagent (Perkin Elmer), and signals
detected with a Fuji LAS-3000 CCD camera. Silver
staining of the 15% polyacrylamide gel was performed
according to ref. (44).
RESULTS
Construction of plasmid-based aptamer-tagged
sRNA genes
To isolate in vivo expressed GcvB, InvR and RybB sRNAs
from Salmonella by aﬃnity chromatography, the sRNA
genes were cloned on plasmids (Figure 2 and Supplemen-
tary Figure S1) and modiﬁed with any of three RNA
aﬃnity tags (Figure 1B). We used the following RNA
aﬃnity tags: (i) a tandem repeat of the 43 (45) or 50nt
(46,47) variant of phage MS2 coat protein binding motif,
to which we will refer as MS2 or MS2*, respectively; (ii)
monomeric (15nt) or tetrameric (72nt) versions of the
 N22 peptide binding sequence (16,48), here referred to
as 1xboxB or 4xboxB, respectively; (iii) a 60nt SELEX-
derived aptamer sequence speciﬁc for the eukaryotic
initiation factor 4A (49) which will be referred to as the
eIF4A aptamer.
Based on prior knowledge of which region in the three
sRNAs were required for target regulation, the aptamer
sequences were introduced at various positions (Figure 3
and Supplementary Figure S1). In GcvB RNA, the
binding site for oppA mRNA is located between stem
loops 1 and 2 [Figure 1A and (35)]; consequently,
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(MS2 and eIF4A-a constructs), or replaced the gcvB trans-
cription terminator (MS2*, eIF4A-b, 1xboxB, 4xboxB). If
an aptamer replaced the native transcription terminator,
transcription was expected to terminate at a plasmid-
borne terminator which derives from the vrrA sRNA
gene of Vibrio species (50) and is located downstream of
the sRNA cloning site. We used the heterologous vrrA
terminator rather than a Salmonella or E. coli terminator
to minimize possible recognition of the RNA 30-end by
Salmonella proteins. Concerning InvR, residues 33–66 of
this RNA constitute the core interaction site for pairing
with the ompD target mRNA [(36), and V. Pfeiﬀer and
J. Vogel, unpublished data]. Therefore, aptamers were
either fused to the 50-end of InvR (MS2, eIF4A-a),
inserted upstream of the invR terminator (1xboxB-a),
or cloned such that the aptamer replaced the invR termina-
tor (MS2*, eIF4A-b, 1xboxB-b, 4xboxB). The ﬁrst 16
residues of RybB are stringently required for pairing to
all omp target mRNAs (51); thus, aptamers were only
cloned at positions downstream of RybB residue 31, by
either insertion (MS2, 1xboxB) or terminator replacement
(MS2*, eIF4A, 4xboxB).
The pZ plasmid series (52) served as building blocks
for construction of our aptamer-tagged sRNA expression
plasmids; the p15A origin used here ensures 20–30 plasmid
copies/cell. InvR and RybB sRNAs were expressed from a
constitutive PLlacO-1 promotor (52) In contrast, GcvB was
expressed from its native promotor since high expression
of this sRNA is lethal in Salmonella (35).
We used two diﬀerent cloning strategies (Figure 2). The
ﬁrst strategy provides plasmids carrying the wild-type
sRNA genes which were ampliﬁed using PCR primers
that introduced the aptamer tag at the desired sRNA
position (Figure 2A). Second, we constructed general
vectors harboring the 1xboxB (pNS-18), 4xboxB
(pNS-20), eIF4A (pNS-19) or MS2* (pNS-21) aptamer
sequences ﬂanked by unique NheI and XbaI cleavage
sites, and followed by the vrrA transcription terminator
(Figure 2B). These vectors facilitate the parallel cloning
of the sRNA of interest and aptamer-tagging at either
the 50-o r3 0-end. The cloned sRNA will then be trans-
cribed from the constitutive PLlacO-1 promotor; alterna-
tively, an XhoI site further upstream in the plasmid
facilitates the insertion of the sRNA gene with its native
promoter. Cloning strategies for the individual constructs
are summarized in the ‘Materials and Methods’ and
Supplementary Methods sections.
Aptamer-tagged sRNAs are stably expressed
and functional in vivo
To test if and how the aptamers impacted on sRNA
stability and function in vivo, Salmonella carrying sRNA
expression plasmids were grown in standard media to
Figure 1. Regulatory sRNAs. Sequences of (A) the Salmonella RybB, InvR and GcvB sRNAs, and (B) the various aptamer tags speciﬁc for phage
MS2 coat protein (MS2 and MS2*), for  N22 peptide (1xboxB and 4xboxB), or the eukaryotic initiation factor 4A (eIF4A) used in the present study.
Shadowed nucleotides denote residues of the three Salmonella sRNAs that are involved in base-pairing to target mRNAs.
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aptamer-tagged versus wild-type sRNAs, both expressed
from plasmid in the corresponding sRNA deletion strain,
were compared on northern blots. In parallel, target
regulation was monitored by western blot detection of
OmpD (InvR), OppA (GcvB) or the major porins
(RybB). The results of these analyses are shown in
Figure 3.
Aptamer-tagged GcvB sRNAs (Figure 3A, lanes 3–8)
were found to be expressed at levels comparable to
wild-type GcvB (lane 2); in all cases the most prominent
GcvB-derived RNA species corresponded with the
expected increase in RNA length upon aptamer-
tagging. Additional prominent higher molecular weight
RNA species were observed with four of the GcvB
constructs that are supposed to terminate with the vrrA
terminator (lanes 4, 6–8); these are likely to result from
transcripts terminating at another terminator (rrnB)
located  50bp downstream on the plasmid. The smaller
bands observed for the MS2* and 4xboxB variants (lanes
4 and 8) may indicate aberrant RNA processing events
or premature termination. Except for MS2* (lane 4) all
RNAs reduced OppA protein levels to the same degree
as wild-type GcvB, which suggests that aptamer tagging
did not impair the regulatory properties of these sRNAs.
However, even the MS2* variant facilitated partial OppA
repression.
In contrast to GcvB, aptamer-tagging strongly
impacted on the steady-state level of InvR RNA (Figure
3B); in fact, only two (lanes 3 and 7) out of seven tagged
InvR RNAs accumulated as a single species and at levels
comparable to wild-type InvR expressed from plasmid.
Interestingly, in both constructs (MS2 and 1xboxB-a)
transcription terminates at the native invR terminator
whereas all but one (eIF4A-a; lane 5) of the less
abundant RNAs are supposed to terminate with the
vrrA sequence. Strikingly, in spite of varying RNA levels
and prominent RNA processing all but two variants
(MS2* RNA; lane 4 and eIF4A-b RNA; lane 6)
down-regulated OmpD protein synthesis comparably to
wild-type InvR.
We constructed ﬁve aptamer versions of RybB RNA
(Figure 3C). Whilst three (MS2, 1xboxB and 4xboxB;
lanes 3, 6 and 7, respectively) accumulated at or close to
wild-type levels, the MS2* (lane 4) and eIF4A (lane 5)
RNAs were unstable. In contrast to GcvB and InvR,
however, almost all RybB variants accumulated as a
single RNA species of the predicted size. Regarding
target (major porin) repression, there was good but not
strictly linear correlation between steady-state levels of the
regulatory RNA and the degree of repression. That is both
the highly expressed MS2 and 1xboxB alleles decreased
OmpA/C/D/F protein levels to the same degree as wild-
type RybB (compare lanes 2, 3 and 6), whereas the poorly
Figure 2. Cloning strategies for plasmids to express aptamer-tagged sRNAs. (A) Strategy I: an aptamer tag is introduced by addition of the sequence
to PCR primers and ampliﬁcation of a plasmid that carries the sRNA gene of interest. This strategy permits the insertion of the aptamer at any
position in the sRNA sequence. (B) Strategy II: alternatively, sRNA fragments are ampliﬁed by PCR and introduced into the general aptamer
cloning vectors, pNS-18, pNS-19, pNS-20 and pNS-21, using unique NheI and XbaI sites. This strategy permits to fuse the aptamer to either the 50-
end (insertion at XbaI site) or 30-end (NheI) of the sRNA. Cloned fragment will be expressed from a PLlacO-1 promoter located immediately upstream
of the NheI site. Alternatively, cloning in the XhoI–NheI region permits expression of an sRNA from its own promoter.
e133 Nucleic Acids Research, 2009,Vol.37, No. 20 PAGE 6 OF 14expressed MS2* RNA (lane 4) largely failed to deplete
the major porins. The eIF4A and 4xboxB RNA (lanes 5
and 7) both facilitated the same degree of intermediate
porin expression, although 4xboxB RNA was consid-
erably more abundant than eIF4A RNA.
When the same type of aptamer was used, the most
drastic diﬀerence in terms of RNA abundance and
regulation was observed with the MS2 and MS2* RNAs
(lanes 3 and 4). The aptamer position is similar in these
two RNAs (fusion to residue +31 or +37, respectively, of
RybB; Figure 3 and Supplementary Figure S1). However,
whereas the MS2 aptamer was merely inserted, i.e.
without deleting any RybB nucleotides, the MS2*
aptamer was cloned such that it replaced the 30-end of
RybB. The similarly composed MS2* versions of GcvB
and InvR were also strongly impaired in target regulation.
Thus, the plasmid-borne cassette of MS2* and vrrA
terminator may not consistently yield stable regulators,
at least in Salmonella.
Taken together, these in vivo experiments suggest that
the successful tagging of bacterial sRNA regulators with
aptamer sequences requires empirical testing of both the
tagging strategy and the insertion site in the sRNA. For
the experiments to follow, we selected MS2-tagged sRNAs
constructed according to cloning strategy I (Figure 2A)
because these yielded the most homogenous transcripts,
and eﬃcient target regulation (Figure 3).
Aﬃnity puriﬁcation of in vivo expressed sRNAs
In order to test whether inserted aptamer sequences enable
the puriﬁcation of in vivo expressed sRNAs, we adapted a
previously established protocol for the isolation of in vitro
assembled spliceosomal RNPs (53) which employs
MS2-MBP. Figure 4 gives an overview of the experimental
steps. Salmonella expressing MS2-tagged sRNAs from
plasmids are collected by centrifugation, followed by
rapid lysis. A cleared lysate is then directly applied to an
amylose column that is non-covalently coupled with
MS2-MBP protein (via amylose binding of the MBP
moiety). Upon binding of the MS2-tagged RNA species
to MS2-MBP, the column is extensively washed to remove
non-speciﬁcally bound RNA. Finally, the tagged sRNA
Figure 3. Expression and target regulation of aptamer-tagged sRNAs.
(A) Northern and western blot analyses of Salmonella gcvB (strain
JVS-3143) carrying an ‘empty’ control vector (lane 1, pNS-17), or
plasmids expressing wild-type (lane 2, pTP005) or aptamer-tagged
GcvB sRNAs (lanes 3–8). The schematic drawing to the left shows
the sRNA sequences in black, aptamer sequence in red, and (where
applicable) the vrrA transcription terminator sequence in green.
Co-transcribed linker sequences unrelated to aptamer, sRNA or vrrA
terminator sequences are shown in grey. The expected length
(in nucleotides) of the expressed RNA is given. Supplementary Figure
S1 presents the sequence of the RNAs and connects the insert names to
the expression plasmids. The top panel shows the relevant section of a
northern blot probed with GcvB-speciﬁc oligonucleotide, JVO-0749.
Asterisks indicate bands of expected full-length sRNAs. Positions of
a co-migrating size marker are shown to the right of the blot.
The middle panel shows probing for 5S rRNA to conﬁrm equal
loading. The bottom panel shows the relevant section of a western
blot probed with a polyclonal serum against OppA protein, whose
synthesis is repressed by GcvB sRNA. The OppA-speciﬁc band is
indicated by an arrowhead. RNA and protein samples were prepared
as described in ‘Materials and Methods’ section. (B) Analyses as above
but of Salmonella invR (JVS-3008) and InvR expression plasmids.
Wild-type InvR sRNA was expressed from plasmid pNS-9, and the
sRNAs were detected with oligonucleotide probe, JVO-0222 (top
panel). The third panel from top shows the section of a western blot
probed with a general anti-porin serum in order to detect down-
regulation of OmpD synthesis by InvR sRNAs. Bottom panel: the
same blot probed for GroEL protein as loading control. (C) Analyses
of Salmonella rybB (JVS-3142) and RybB plasmids (pNS-13 for
expression of wild-type RybB). Detection of the sRNA (top panel)
was done with oligonucleotide probe, JVO-2644. Regulatory activity
of the sRNAs was evaluated by western blot probing of major porins
(third panel from top) whose synthesis is negatively controlled
by RybB.
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maltose-containing buﬀer that disrupts the MBP–
amylose interaction.
All experiments described below were carried out in
Salmonella strains in which the chromosomal copy of
the sRNA of interest was deleted. We used plasmids
expressing the 247nt GcvB-MS2, the 130nt InvR-MS2,
or the 122nt RybB-MS2 sRNAs (Figure 3 and Supple-
mentary Figure S1). Parallel experiments with plasmids
expressing the cognate wild-type sRNAs were used to
determine the degree of unspeciﬁc column binding.
Comparative northern blot analysis of the eluted
fractions (Figure 5A, lane 5) showed that the MS2 tag
permitted the speciﬁc isolation of a tagged sRNA as
compared to the cognate wild-type sRNA. Quantiﬁcation
of the northern blot signals in the lysate (input) and eluted
fractions suggested that 9% of InvR-MS2 RNA was
recovered. In contrast, only 0.14% of wild-type InvR
RNA (which is expressed from the plasmid at the same
level; Figure 3B) was recovered, arguing that InvR-MS2
RNA was enriched 65-fold as compared to wild-type
InvR. Of the other two MS2-tagged sRNAs, GcvB and
RybB, 3.5 and 22%, respectively, were recovered from
the original lysate. Based on comparison to the eluted
fractions of the wild-type sRNA samples, this suggested
55-fold (GcvB) or 135-fold (RybB) enrichment.
Regardless of the enrichment, we note a considerable
loss of RNA already in the lysate samples; this may be
caused by rapid RNA degradation in the course of cell
disruption. In addition, although the bait protein was in
molar excess over expressed RNAs (see quantiﬁcation
below), comparison of the ﬂow-through fractions of the
tagged versus untagged RNAs showed that generally
<20% of the MS2-tagged sRNAs bound to the column.
To address in a more quantitative manner which
amounts of the MS2-tagged RNAs were recovered by
the above aﬃnity puriﬁcations, sRNA-speciﬁc northern
blot signals of eluted RNA fractions were compared to
the signal obtained with known quantities of in vitro
transcribed sRNA (Supplementary Figure S3). From a
starting material of 5 10
10 (A600 of 50) bacteria,
0.35pmol ( 25ng) of GcvB-MS2, 2.5pmol ( 100ng) of
InvR-MS2, and 2.1pmol ( 80ng) of RybB-MS2 were
puriﬁed. Thus, the MS2-tagged sRNAs were recovered
in quantities that should permit downstream biochemical
analysis.
Co-puriﬁcation of Hfq protein
InvR, GcvB and RybB belong to a class of bacterial
sRNAs that strictly depend on the Sm-like protein, Hfq,
for both intracellular stability and target regulation
(35,36,54). All three sRNAs are enriched by co-immuno-
precipitation (coIP) of Hfq in Salmonella lysates (30,32),
suggesting that they form stable complexes with Hfq in
vivo. Therefore, if the MS2-MBP aﬃnity approach
indeed recovered sRNAs in their native form, Hfq
protein should not only be detectable in the eluted
fraction, but also considerably enriched with the
MS2-tagged sRNAs as compared to untagged wild-type
sRNAs.
We expressed the sRNAs in a Salmonella hfq
3 FLAG
strain which provided a means to detect Hfq protein on
western blots by way of the added FLAG epitope (30).
Figure 5B shows that Hfq was recovered with all three
MS2-tagged sRNAs, whereas little (InvR) or no (GcvB,
RybB) Hfq was detected in the elute fraction of the
untagged counterparts of these sRNAs. This suggested
that Hfq was puriﬁed along with the RNA, rather than
by unspeciﬁc interaction with the column-bound
MS2-MBP protein.
Next, Hfq
3 FLAG protein was over-expressed in E. coli
and puriﬁed to homogeneity. Dilution series of the
puriﬁed protein were then probed along with the protein
samples from the elute fractions of MS2-tagged sRNAs, in
order to determine the number of Hfq molecules that were
co-puriﬁed with these sRNAs (Supplementary Figure S3).
We determined 1.0, 2.6 or 1.1pmol Hfq (monomer) in the
elute fractions of GcvB-MS2, InvR-MS2, or RybB-MS2,
respectively. Our successful aﬃnity puriﬁcation of Hfq
protein along with MS2-tagged RNAs (Figure 5) was in
Figure 4. Experimental strategy to purify MS2 aptamer-tagged sRNAs
and possibly in vivo formed RNPs under non-denaturing conditions
from bacterial lysates. Red lines denote aptamer tags, yellow and
green circles the MS2 coat protein and the maltose-binding protein
(MPB) moieties of the MS2–MBP fusion protein that binds to the
subunits of the amylose column (black circles).
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RybB wild-type sRNAs showing (i) their enrichment by
Hfq coIP (30,31,55) and (ii) their lower nanomolar
binding aﬃnities for puriﬁed Hfq in vitro (35–37).
However, none of this excluded the possibility that Hfq
primarily associated with the MS2 moiety rather than the
sRNA sequence. To address this, we expressed in
Salmonella a short RNA comprised of the MS2 tag
followed by the RNA sequence of the rrnB transcription
terminator (plasmid pRR-05). This  80nt MS2 RNA was
stable in vivo, and could be recovered by MS2-MBP
aﬃnity puriﬁcation in amounts comparable with the
MS2-tagged sRNAs (Figure 5). Western blot analysis of
the elute fraction determined 0.1pmol Hfq. Given this
weak association of Hfq with MS2 alone, the signiﬁcantly
higher recovery of Hfq with MS2-tagged sRNAs argues
that the latter were puriﬁed as an Hfq-containing RNP
that speciﬁcally assembled on the tagged sRNAs.
Optimized aﬃnity puriﬁcation
The successful co-puriﬁcation of Hfq with MS2-tagged
InvR sRNA was taken as a departure point to improve
the initial protocol. Speciﬁcally, we asked whether the
incubation time with MS2-MBP fusion protein inﬂuences
the recovery of tagged sRNA from the cell lysate. Cell
extracts containing MS2-tagged InvR or native InvR
were subjected to aﬃnity chromatography either without
any preincubation with the protein or after 20, 50 or
70min, respectively (Supplementary Figure S4A). The
results indicate that speciﬁc and eﬃcient binding occurs
immediately and preincubation is not necessary.
Therefore, the cell lysate can be loaded directly on the
prepared MS2-MBP/amylose resin to decrease the
possibility of RNA degradation and RNP complex
dissociation.
We further asked which parameters can be changed to
increase the isolation yield of sRNA associated proteins.
To test the inﬂuence of the quantity of bait protein,
columns were loaded with 10, 50, 100 and 200pmol
MS2-MBP protein. Supplementary Figure S4B shows
that increasing MS2-MBP amounts do increase the yield
of Hfq
3 FLAG co-puriﬁed with InvR-MS2 RNA, yet that
10pmol of MS2-MBP suﬃce for eﬃcient co-puriﬁcation,
at least for this sRNA. Note that high amounts of
MS2-MBP protein seem to increase unspeciﬁc binding,
i.e. Hfq
3 FLAG protein becomes detectable in the elute
fraction of wild-type InvR RNA loaded onto a column
with 200pmol MS2-MBP protein (Supplementary
Figure S4B).
Salt concentration can have a profound positive eﬀect
on RNA folding and the stability of non-covalent
RNA–protein interactions during the course of
puriﬁcation (56–58). We tested the eﬀects of KCl by
increasing its concentration in all buﬀers from 150mM
to 1M. Figure 6 shows that 1M KCl permitted better
co-puriﬁcation of Hfq
3 FLAG with InvR-MS2 RNA and
revealed that the increase in salt concentration did not
Figure 5. (A) Aﬃnity puriﬁcation of in vivo expressed MS2-tagged GcvB, InvR and RybB sRNAs. Shown are northern blot analyses of RNA
prepared before, during or after the aﬃnity puriﬁcation described in the ‘Materials and Methods’ section. We analyzed Salmonella strains
hfq
3 FLAGsRNA or hfq
3 FLAG harboring the RNA expression plasmids (from top to bottom: pNS-7 and pTP005 in strain JVS-3790, pNS-10
and pNS-9 in strain JVS-3618, pNS-14 and pNS-13 in strain JVS-3789 and pRR-05 in strain JVS-3616). RNA samples were prepared from intact
cells before lysate preparation (lane 1), from the cleared lysate shortly before loading onto the column (lane 2), from the ﬂow-through fraction
collected after loading on a column pre-incubated with MS2-MBP protein (lane 3), from the combined column wash fractions (lane 4) and of the
eluate (lane 5). Note that the amount of RNA loaded in lanes 1–4 each corresponds to 1 OD600 of bacterial culture, but in lane 5 the eluate
corresponds to 10 OD600 of culture. Oligonucleotide probes to detect sRNAs were as in Figure 3; the MS2 control RNA was detected using JVO-
3562. Comparison of the sRNA signal in the eluates of a wild-type sRNA versus its MS2 variant proves the speciﬁc isolation of the aptamer-tagged
sRNAs. (B) Co-puriﬁcation of Hfq with MS2-tagged sRNAs. Protein fractions of the samples shown in (A) were analyzed on western blot using a
monoclonal antibody directed against the FLAG-epitope tag of the Hfq
3 FLAG protein. Loaded protein samples correspond to 0.05 OD600 of
bacterial culture for lanes 1–4 and to 10 OD600 for the eluate (lane 5). Enrichment of Hfq
3 FLAG in the eluate samples of MS2-tagged GcvB, InvR
and RybB, but not of MS2 control RNA argues that the protein was bound to the sRNA rather than the MS2 sequence.
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Interestingly, the silver-stained gels also revealed that the
elute fraction equivalent to 5 10
10 Salmonella cells (or
25ml of a stationary phase bacterial culture) were
suﬃcient to visualize the Hfq
3 FLAG protein that
co-puriﬁed with InvR-MS2 RNA. The amount of
associated proteins was suﬃcient to perform a ﬁrst
proteome analysis by liquid chromatography tandem
mass spectrometry (LC-MS/MS) of the tagged (InvR-
MS2) RNP complexes. Table S4 summarizes the
proteins that were identiﬁed. Hfq could exclusively be
detected in the MS2 tagged sample but not in the non-
tagged control.
MS2-tagging of a chromosomal sRNA gene
Additionally to the aptamer-tagging of sRNAs on
plasmids, we have developed a strategy for MS2-tagging
of chromosomal loci in order to purify sRNAs without
any over-expression. To integrate the aptamer tag into
the sRNA gene, we adapted a gene replacement strategy
based on the one-step inactivation of chromosomal genes
(40). Using a two-step PCR approach, a DNA fragment is
generated that contains the aptamer-tagged sRNA and an
antibiotic resistance gene, and which is then used to
replace the wild-type sRNA gene by  Red-mediated
recombination (Figure 7A). The rybB gene is directly
activated by the envelope stress sigma factor, s
E (37).
We determined that within 10min following s
E induction,
MS2-tagged RybB accumulated to comparable RNA
levels as RybB of a wild-type strain (Figure 7B), and
that the tagged RNA down-regulated the well-established
ompN mRNA target (37,51) with the same kinetics as
wild-type RybB (Figure 7B), arguing that the MS2 tag
did not compromise RybB’s activity as an ompN
repressor.
For RNA aﬃnity puriﬁcation (Figure 7C), samples
were withdrawn 5min after s
E induction. As before, we
could recover the MS2-tagged RybB sRNA along with
Hfq protein. Speciﬁcally, we obtained  1.2pmol
( 50ng) MS2-tagged RybB and  7pmol ( 100ng) Hfq
from a lysate of 200 OD600 of bacterial culture. This
indicates that, on average, each puriﬁed RybB-MS2
molecule was associated with one Hfq hexamer, which is
in perfect agreement with the stochiometry of a RybB/Hfq
complex formed in vitro (37).
DISCUSSION
There have been several studies to identify sRNA-binding
proteins by way of aﬃnity puriﬁcation from lysates of
E. coli cells. Wassarman and Storz (59) used a DNA
antisense oligonucleotide directed against an extended
loop region of the otherwise highly structured 6S RNA,
which led to the discovery of the tight association of 6S
RNA with RNA polymerase (RNAP). The Schroeder
laboratory have extensively used in vitro-transcribed
variants of E. coli sRNAs which carried a streptomycin
aptamer tag in order to purify proteins that would bind to
these sRNA upon incubation with E. coli lysates (9,60).
Mass spectrometry analysis of the puriﬁed protein
fractions conﬁrmed many predicted sRNA–protein
interactions, e.g. 6S RNA/RNAP, CsrB/CsrA or OxyS/
Hfq, and also revealed unexpected interactions of several
sRNAs with RNAP or ribosomal S1 protein (60). In a
further study, in vitro-transcribed  70nt Rcd RNA of
plasmid ColE1 was cross-linked to CNBr-activated
sepharose, followed by incubation with E. coli lysates;
step-wise elution of the retained proteins identiﬁed the
enzyme, tryptophanases, as a novel target of this small
RNA regulator (61).
The present study aimed at establishing whether
bacterial sRNAs can be successfully modiﬁed by the
addition of aptamer sequences such that they would (i)
retain regulatory properties in vivo, and (ii) be recovered
as an in vivo assembled RNP with their natural binding
partner, Hfq, via RNA-based aﬃnity puriﬁcation. The
results obtained with three model sRNAs of Salmonella
suggest that successful tagging in terms of maintaining a
homogenous RNA population will require empirical
testing of several aptamers and insertion points, and that
of the aptamer sequences tested here, the MS2 tag is likely
to work best.
The in vivo expression of the aptamer-tagged
sRNAs may oﬀer advantages in comparison to solely
in vitro-based methods. First, the functionality of the
tagged sRNA can be tested by ﬁrst scoring its native
regulatory function in vivo. That is the integration of
Figure 6. Several proteins co-purify with MS2-tagged InvR sRNA.
Proteins of the lysate, ﬂow-through, wash (0.1 OD600) and eluate
(50 OD600) fractions were separated on an SDS-gel and stained with
silver. Positions of the eluted MS2-MBP, the endogenous MBP of
Salmonella (marked by an asterisk) and the co-puriﬁed FLAG-tagged
Hfq are indicated right to the gel. Lysis with French press and aﬃnity
chromatography were performed with buﬀer A containing either the
standard concentration of 150mM KCl, or 1M KCl. The eluate
fractions of the aﬃnity chromatography using the increased KCl
concentration were analysed by mass spectrometry. Positions of
co-migrating size marker proteins (in kDa) are shown to the left.
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that are mostly  150nt in length (62) inevitably comes
with the risk of intramolecular structural interference,
impairing the folding of the sRNA or shielding its target
interaction regions. Second, in vivo transcription of sRNA
and its target mRNA(s) might be crucial for correct
assembly of active RNPs, whereas in vitro transcribed
RNA could be trapped in an inactive fold due to
absence of auxiliary factors that act co-transcriptionally
in vivo. Third, reversible formaldehyde cross-linking
in vivo which is commonly used to identify RNA–protein
interactions may capture very transient RNPs that
promote key kinetic steps in sRNA-mediated target
recognition/regulation; the cross-linking may limit the
loss of weakly associated factors. Last, expression of
aptamer-tagged sRNAs may not only be useful for RNP
puriﬁcation but may also permit visualization of spatial
expression pattern of an sRNA in vivo. That is GFP fusion
proteins to MS2 or eIF4A have been successfully used to
visualize the in vivo distribution of mRNA or 5S rRNA,
respectively, in E. coli (49,63).
To isolate in vivo assembled sRNA–protein complexes,
antisense oligonucleotides binding to regions that remain
accessible in the wild-type RNA after complex formation
has been amply used. This method has the advantage
that tagging of the RNA is not required, and it has
been successfully applied to, e.g. the isolation of well-
established spliceosomal and telomerase complexes (6,7).
However, puriﬁcation via aﬃnity oligonucleotides are
usually more dependent on the proper salt concentrations
than an aptamer approach. In general, little is known
about the structure and thus the accessible regions of
bacterial sRNAs in vivo. Therefore, the aptamer and the
oligonucleotide approach equally bear the risk of missing
crucial protein interactions if the targeted region is only
accessible in a subcomplex.
Puriﬁcation of in vivo formed RNPs using aptamer-tags
was not previously described in prokaryotes. Whilst our
study focused on three aptamer tags for the MS2-coat
protein,  N22 peptide, and the eukaroytic initiation
factor 4A, other aptamers remain to be tested. For
example, active RNase P was successfully isolated from
yeast following tagging of the RNA component of
RNase P with a streptavidin aptamer (8). Recently,
RNA aﬃnity in tandem (RAT) was described (17).
Here, the combinational use of the aptamer sequence
binding to the Pseudomonas phage 7 coat protein and
the tobramycin aptamer allowed the puriﬁcation of
human 7SK RNPs.
However, there are several important issues to be
considered for any sRNAs to be studied with our
tagging approach in the future. In the present study, we
Figure 7. Analysis of chromosomally tagged RybB sRNA. (A) A PCR-product containing the MS2-tagged sRNA ﬂanked by homologous regions
(H1 and H2) to the sRNA locus is integrated into the bacterial chromosome via  Red-mediated recombination. The integrated sRNA is selected by
the attached antibiotic resistance gene. (B) Northern blot analysis of chromosomally expressed RybB RNAs (under control of sE) and ompN target
mRNA. Wild-type Salmonella (JVS-0007) and Salmonella with chromosomally MS2-tagged RybB (rybB-MS2, JVS-4892) carrying a control plasmid
(pBAD) or an arabinose-inducible sE expression plasmid (pBAD–RpoE) were induced in early stationary phase. RNA was prepared prior to (0min)
and at 2, 5 and 10min following induction, and probed as indicated. (C) Aﬃnity puriﬁcation. Prior to collection and lysis, Salmonella strains JVS-
4279 and JVS-3617, both carrying the pBAD–RpoE expression plasmid, were grown to late exponential phase (OD600 of 1) and sE expression was
induced for 5min. Aﬃnity puriﬁcation and northern (RybB probe) and western (via the FLAG tag of Hfq) blot analyses were performed as in Figure
5 but loading eluate samples equivalent to 20 OD600 of bacterial culture.
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(of InvR and RybB; Supplementary Figure S2) to ensure
suﬃcient and comparable expression of the various
sRNAs under the growth conditions used here. It is
important to stress, though, that over-expression of the
tagged sRNAs may allow them to function even if they
are not as active as the endogenous sRNAs, or if they
comprise a mixed pool of active and non-active
sRNAs.In addition, the sRNA may form complexes
with mRNAs and/or proteins that would not be targeted
by native expression levels; may act indirectly by titrating
Hfq, thereby aﬀecting the stability of other molecules;
and might dilute a relevant protein in the pool of
isolated RNPs. In this respect, our demonstration that a
chromosomally encoded RybB-MS2 sRNA is fully
functional as an envelope stress-induced ompN repressor
should encourage integration of tagged sRNAs in the
chromosome after initial testing on plasmids.
Homogeneity of the expressed sRNAs is another issue.
In this regard, if the insertion of the aptamer yield in an
sRNA that retained its natural terminator sequences
(Figures 2A and 3), the RNAs are mostly expressed as
homogenous species and in levels comparable the wild-
type sRNAs. However, for constructs using the plasmid-
borne vrrA terminator we often observe aberrant
processing and transcriptional read-through into the
downstream located rrnB terminator (Figures 2B and 3).
We do not currently understand the reason for the
observed heterogeneity of transcripts in those latter
cases. That is, the terminator of the Vibrio VrrA sRNA
gene was chosen because it represents a heterologous
sRNA terminator expected to have little inﬂuence on
sRNA function in Salmonella, and which had been
known to produce a single-sized VrrA RNA in both
Vibrio and Salmonella (50). Although most of our
tagged sRNAs to terminate at vrrA seem to be still
functional in vivo, at least when over-expressed (Figure
3), it seems advisable to integrate the aptamer such that
the original sRNA terminator is retained.
Whilst the general yield of puriﬁed RNA and protein is
in the practical range for biochemical studies (see below),
we note that generally <20% of MS2-tagged sRNA
present in the lysate were captured on the MS2-MBP
column (compare lanes 2 and 3 in Figure 5). In
comparison, others have reported recovery rates between
12 and 90% when using in vitro transcribed streptotag-
modiﬁed E. coli sRNAs and the respective matrix (60).
However, diﬀerences in the tested sRNAs as well as the
fact that sRNAs were bound to the column prior to lysate
application preclude a direct comparison. Regardless, if a
given sRNA is only partially retained on the column
(because of shielding of the aptamer by a protein or by
improper folding), we must at least consider the possibility
that the puriﬁed sRNA may not fully represent the active
regulatory complex.
Protein visualization and comparative quantiﬁcation by
standard laboratory techniques, e.g. SDS–PAGE, requires
minimal concentrations of co-puriﬁed proteins. The lower
detection limit for proteins using standard gel staining
methods is  2–10ng (silver staining) or  10–100ng
(Coomassie) per protein band (64). It is worthwhile to
mention that we could easily detect an Hfq band upon
co-puriﬁcation with plasmid-expressed InvR-MS2 RNA
(Figure 6). Therefore, our approach should be successful
to recover at least the major binding partner of a sRNA of
interest. Indeed a ﬁrst MS-based proteome analysis
revealed proteins associated with InvR-MS2 in addition
to the expected Hfq protein (Table S4). Further studies of
the detected proteins are ongoing.
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